✦ LIBER ✦

8506 Cisplatin dose intensity correlates with outcome in patients with locally advanced head and neck squamous cell carcinoma receiving concurrent cisplatin based chemoradiation: a multi-institutional experience

✍ Scribed by Granata, R.; Pond, G.; Kim, J.; Siu, L.L.; Olmi, P.; Orlandi, E.; Bossi, P.; Locati, L.D.; Licitra, L.

Book ID: 123480716
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71597-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Response Analysis of TPF (d

Efficacy and Response Analysis of TPF (docetaxel, Cisplatin, 5-fu) Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation Only in Patients with Locally Advanced Squamous Cell Carcinomas of Head and Neck

✍ Mehta, M.J.; Nandwani Patel, P.; Neema, J.; Vyas, R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Hyperfractionated radiation therapy with

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vask 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 12 KB

Docetaxel, cisplatin, and 5-fluorouracil

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience

✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime

Multi-institution Analysis of Concurrent

Multi-institution Analysis of Concurrent Chemoradiation Therapy With Cisplatin (CDDP) Versus Cetuximab (C225) in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent?

✍ Riaz, N.; Baschnagel, A.; Adkins, D.; Rao, S.; Huang, J.; Chen, P.; Ley, J.; Kra 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Multi-institution Analysis of Concurrent

Multi-institution Analysis of Concurrent Chemoradiation Therapy With Cisplatin (CDDP) Versus Cetuximab (C225) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent?

✍ Riaz, N.; Baschnagel, A.; Adkins, D.; Rao, S.; Huang, J.; Chen, P.; Ley, J.; Kra 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase II study of weekly high-dose cispl

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck

✍ A.S.T. Planting; P.H.M. de Mulder; A. de Graeff; J. Verweij 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 694 KB